08:45 AM EST, 02/03/2025 (MT Newswires) -- (Updates with Becton Dickinson's ( BDX ) response to a request for comment in the last paragraph.)

Becton Dickinson ( BDX ) is considering a potential separation of its life sciences division, according to media reports.

The push to separate the business via a sale or spin-off is coming from activist investor Starboard Value, which has taken a stake in the company, the Financial Times reported Monday. A sale could value the division at about $30 billion, Bloomberg reported, while the Financial Times reported the unit could be worth $33 billion to $35 billion, citing Citigroup ( C ) analysts.

A spokesperson for Becton Dickinson ( BDX ) declined to comment to MT Newswires.